Home/Corvus Pharmaceuticals/Jeffrey Arcara

JA

Jeffrey Arcara

Chief Business Officer

Corvus Pharmaceuticals

Therapeutic Areas

Oncology Immunology

Corvus Pharmaceuticals Pipeline

Drug	Indication	Phase
Soquelitinib (CPI-818)	Relapsed/Refractory T Cell Lymphomas	Phase 1/1b

Leadership Team at Corvus Pharmaceuticals

Richard A. Miller, M.D.

President, CEO, Co-Founder

Chief Financial Officer

Otute Akiti, Ph.D.

Vice President, CMC

William Ben Jones, Ph.D.

Senior Vice President, Pharmaceutical Development

Gabriel Luciano

Vice President, Clinical Operations

View full Corvus Pharmaceuticals profile